Evidence map›Paper›PMID 28767067›Full record

ArticleMarine drugs2017

Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.

Te-Chih Cheng, Zhong-Hao Din, Jui-Hsin Su, Yu-Jen Wu, Chih-I Liu

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Translational cancer research · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Stellettin B Isolated fromInternational journal of cell biology · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Te-Chih ChengDepartment of Nursing, Mei-ho University, Pingtung 91202, Taiwan. x00003077@meiho.edu.tw.
Zhong-Hao DinGraduate Institute of Applied Healthy and Biotechnology, Mei-ho University, Pingtung 91202, Taiwan. a0981709760@gmail.com.
Jui-Hsin SuTaiwan Coral Research Center, National Museum of Marine Biology and Aquarium, Pingtung 94446, Taiwan. x2219@nmmba.gov.tw.
Yu-Jen WuDepartment of Biological Technology, Mei-ho University, Pingtung 91202, Taiwan. wyr924@ms24.hinet.net.
Chih-I LiuDepartment of Nursing, Mei-ho University, Pingtung 91202, Taiwan. x00002180@meiho.edu.tw.
Meiho University · TWNational Museum of Marine Biology and Aquarium · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinulariolide is a natural product extracted from the cultured-type soft coral

Indexed as

AnimalsAnthozoaCell MovementDiterpenesHumansMatrix MetalloproteinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTissue Inhibitor of Metalloproteinase-2TOR Serine-Threonine KinasesUrinary Bladder NeoplasmsUrokinase-Type Plasminogen ActivatorDiterpenesMatrix MetalloproteinasesMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktsinulariolideTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2TOR Serine-Threonine KinasesUrokinase-Type Plasminogen Activatorhuman bladder cancerinvasionmigrationPI3K/AKT/mTOR signaling pathwaysinulariolide

Identifiers

PMID28767067
PMCPMC5577593
OpenAlexW2657564268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.